FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to a method of treating endometriosis based on an experimental model in rats, which consists in the fact that the endometriosis model produced by the surgical intervention involves intraperitoneal administration of an oxytocin receptor antagonist in dose of 0.35 mg/kg every day for 21 days.
EFFECT: present invention provides treating endometriosis with the possibility of not using hormonal agents and avoiding the disadvantages of using them and widens the range of products for treating endometriosis.
1 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ENDOMETRIOSIS IN EXPERIMENT IN RATS | 2023 |
|
RU2816983C1 |
| DRUG BASED ON STEROID ESTROGENS FOR TREATMENT OF ENDOMETRIOSIS | 2021 |
|
RU2755250C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| METHOD FOR FORMING AN EXPERIMENTAL MODEL OF A COMBINATION OF TYPE 1 DIABETES MELLITUS AND ENDOMETRIOSIS | 2021 |
|
RU2776727C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2018 |
|
RU2693050C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2711658C1 |
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| METHOD FOR INTEGRATED TREATMENT OF EXTERNAL GENITAL ENDOMETRIOSIS | 2013 |
|
RU2541089C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2727299C1 |
| METHOD TO PREDICT RECURRENCE OF INFILTRATIVE PELVIC ENDOMETRIOSIS BASED ON THE RESULT OF EXPRESSION OF IMMUNOHISTOCHEMICAL MUSASHIL MARKER IN ENDOMETRIOIDAL TISSUE | 2016 |
|
RU2636506C1 |
